PLA2R1 and membranous glomerulonephritis: The refractory disease may additionally be assessed by the persistence of anti-PLA2R antibodies at high or unchanged levels or beyond a specific threshold level in patients with anti-PLA2R antibodies positive membranous nephropathy.